Surrogate End-Points or Primary Outcomes in Clinical Trials in Women with Polycystic Ovary Syndrome?

    June 2004 in “ Human Reproduction ”
    Richard S. Legro, Evan R. Myers
    Studysummary This review discusses the challenges of using surrogate variables versus primary clinical end-points in PCOS trials and reports no new research results; the authors suggest focusing future studies on primary outcomes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Objective Assessment of Treatment Response in Hirsutism Hormone research · 2008
    2. Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association? Endocrine Reviews · 2003
    3. A Prospective Study of the Prevalence of Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain The Journal of Clinical Endocrinology and Metabolism · 2000
    4. Prevalence of Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study The Journal of Clinical Endocrinology and Metabolism · 1998

    Related research 1

    1. Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women PLOS ONE · 2015